EOLS
EVOLUS, INC.
Company Overview
Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market Cap$612.4M
Employees353
CEODavid Moatazedi
Websitehttps://www.evolus.com
Valuation
Current Price$9.3
Fair Value?$000.00
Valuation?No valuation
Hist. PE ?N/Aⓘ
EPS (TTM) ?-0.52
Forward EPS Growth ?—
Historical Growth ?15.01%
Equity, FCF, Long Term Debt, Net Profit, and Shares Outstanding history charts are available on the Pro plan for just $9.99/month.Sign in to unlock Pro
Price
EPS
Revenue
Equity
ProAvailable on the Pro plan
Free Cash Flow
ProAvailable on the Pro plan
Long Term Debt
ProAvailable on the Pro plan
Net Profit
ProAvailable on the Pro plan
Shares Outstanding
ProAvailable on the Pro plan
Last updated: 9/5/2026, 6:14:47 PM